164 related articles for article (PubMed ID: 32954523)
1. Increased MxA protein expression and dendritic cells in spongiotic dermatitis differentiates dermatomyositis from eczema in a single-center case-control study.
Zeidi M; Chen KL; Patel B; Ravishankar A; Lim R; Werth VP
J Cutan Pathol; 2021 Mar; 48(3):364-373. PubMed ID: 32954523
[TBL] [Abstract][Full Text] [Related]
2. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.
Shrestha S; Wershil B; Sarwark JF; Niewold TB; Philipp T; Pachman LM
Arthritis Rheum; 2010 Sep; 62(9):2813-22. PubMed ID: 20506305
[TBL] [Abstract][Full Text] [Related]
3. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
Uruha A; Nishikawa A; Tsuburaya RS; Hamanaka K; Kuwana M; Watanabe Y; Suzuki S; Suzuki N; Nishino I
Neurology; 2017 Jan; 88(5):493-500. PubMed ID: 28039312
[TBL] [Abstract][Full Text] [Related]
4. The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.
Lu X; Tang Q; Lindh M; Dastmalchi M; Alexanderson H; Popovic Silwerfeldt K; Agerberth B; Lundberg IE; Wick C
J Autoimmun; 2017 Mar; 78():46-56. PubMed ID: 28012697
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis.
Uruha A; Allenbach Y; Charuel JL; Musset L; Aussy A; Boyer O; Mariampillai K; Landon-Cardinal O; Rasmussen C; Bolko L; Maisonobe T; Leonard-Louis S; Suzuki S; Nishino I; Stenzel W; Benveniste O
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):513-522. PubMed ID: 30267437
[TBL] [Abstract][Full Text] [Related]
6. Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
Soponkanaporn S; Deakin CT; Schutz PW; Marshall LR; Yasin SA; Johnson CM; Sag E; Tansley SL; McHugh NJ; Wedderburn LR; Jacques TS
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):410-420. PubMed ID: 29770465
[TBL] [Abstract][Full Text] [Related]
7. Myeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness.
Chen KL; Patel J; Zeidi M; Wysocka M; Bashir MM; Patel B; Maddukuri S; White B; Werth VP
J Invest Dermatol; 2021 Aug; 141(8):1906-1914.e2. PubMed ID: 33675790
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
Wenzel J; Schmidt R; Proelss J; Zahn S; Bieber T; Tüting T
Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.
Greenberg SA; Pinkus JL; Pinkus GS; Burleson T; Sanoudou D; Tawil R; Barohn RJ; Saperstein DS; Briemberg HR; Ericsson M; Park P; Amato AA
Ann Neurol; 2005 May; 57(5):664-78. PubMed ID: 15852401
[TBL] [Abstract][Full Text] [Related]
10. Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis.
Zhang SH; Zhao Y; Xie QB; Jiang Y; Wu YK; Yan B
Br J Dermatol; 2019 May; 180(5):1090-1098. PubMed ID: 29947075
[TBL] [Abstract][Full Text] [Related]
11. Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma.
Ross RL; Corinaldesi C; Migneco G; Carr IM; Antanaviciute A; Wasson CW; Carriero A; Distler JHW; Holmes S; El-Sherbiny YM; McKimmie CS; Del Galdo F
Ann Rheum Dis; 2021 Jul; 80(7):920-929. PubMed ID: 33542104
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus.
McNiff JM; Kaplan DH
J Cutan Pathol; 2008 May; 35(5):452-6. PubMed ID: 18005168
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cells in skin lesions of classic Kaposi's sarcoma.
Karouni M; Kurban M; Abbas O
Arch Dermatol Res; 2016 Sep; 308(7):487-92. PubMed ID: 27372661
[TBL] [Abstract][Full Text] [Related]
14. Possible role of plasmacytoid dendritic cells in pityriasis lichenoides.
Karouni M; Rahal JA; Kurban M; Kibbi AG; Abbas O
Clin Exp Dermatol; 2018 Jun; 43(4):404-409. PubMed ID: 29349807
[TBL] [Abstract][Full Text] [Related]
15. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.
Moneta GM; Pires Marafon D; Marasco E; Rosina S; Verardo M; Fiorillo C; Minetti C; Bracci-Laudiero L; Ravelli A; De Benedetti F; Nicolai R
Arthritis Rheumatol; 2019 Jun; 71(6):1011-1021. PubMed ID: 30552836
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis.
Cohen JN; Bowman S; Laszik ZG; North JP
J Am Acad Dermatol; 2020 Feb; 82(2):430-439. PubMed ID: 31859047
[TBL] [Abstract][Full Text] [Related]
17. Perimysial microarteriopathy in dermatomyositis with anti-nuclear matrix protein-2 antibodies.
Liu Y; Zheng Y; Gang Q; Xie Z; Jin Y; Zhang X; Deng X; Hao H; Gao F; Zhang Z; Xiong H; Zhang W; Wang Z; Yuan Y
Eur J Neurol; 2020 Mar; 27(3):514-521. PubMed ID: 31571350
[TBL] [Abstract][Full Text] [Related]
18. Myxovirus resistance protein A (MxA) expression in myositides: Sarcoplasmic expression is common in both dermatomyositis and lupus myositis.
Xing C; Trivedi J; Bitencourt N; Burns DK; Reisch JS; Cai C
Muscle Nerve; 2024 May; 69(5):548-555. PubMed ID: 38372203
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.
Furie R; Werth VP; Merola JF; Stevenson L; Reynolds TL; Naik H; Wang W; Christmann R; Gardet A; Pellerin A; Hamann S; Auluck P; Barbey C; Gulati P; Rabah D; Franchimont N
J Clin Invest; 2019 Mar; 129(3):1359-1371. PubMed ID: 30645203
[TBL] [Abstract][Full Text] [Related]
20. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.
Magro CM; Segal JP; Crowson AN; Chadwick P
J Cutan Pathol; 2010 Jun; 37(6):659-71. PubMed ID: 19891658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
